ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

21,017Medicare Part D Prescriptions Filled, Including Refills

Rank: 25 out of 1692

$1.84M Total Retail Price of All Prescriptions

Rank: 4 out of 1692

567 Patients Receiving at Least One Drug in Part D
95%Patients 65 Years and Older
89% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Virginia
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

7% of this provider’s 567 patients filled at least one prescription for a schedule three drug, compared to an average of 9%.

Risky Drugs to Seniors

1% of this provider’s 20,011 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

43% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$88 was the average price of a prescription from this provider, compared to $55 among peers.

Prescriptions per Patient

37 is the average number of prescriptions (including refills) per patient, compared to an average of 18.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Virginia
SIMVASTATIN 1,201 1,145 1 1
AMLODIPINE BESYLATE 808 787 2 3
DIOVAN HCT 762 746 3 73
LIDODERM 676 662 4 138
ATORVASTATIN CALCIUM 638 611 5 11
OMEPRAZOLE 622 617 6 5
DIOVAN 614 594 7 42
METFORMIN HCL 488 449 8 8
LEVOTHYROXINE SODIUM 442 430 9 4
PRAVASTATIN SODIUM 377 361 10 12
METFORMIN HCL ER 331 331 11 49
CELEBREX 326 326 12 103
TAMSULOSIN HCL 304 278 13 31
LOSARTAN POTASSIUM 291 287 14 17
NEXIUM 289 282 15 25
CRESTOR 271 271 16 26
BYSTOLIC 240 240 17 129
METOPROLOL SUCCINATE 235 235 18 18
LISINOPRIL 224 209 19 2
RANITIDINE HCL 223 220 20 28
LOSARTAN-HYDROCHLOROTHIAZIDE 222 219 21 38
NAMENDA 215 215 22 50
JANUVIA 214 214 23 72
MELOXICAM 213 207 24 41
CARVEDILOL 208 185 25 24
FUROSEMIDE 207 172 26 7
ALENDRONATE SODIUM 201 201 27 36
LIPITOR 199 193 28 119
BENICAR HCT 180 180 29 229
METOPROLOL TARTRATE 175 154 30 10
SINGULAIR 174 174 31 79
ZOLPIDEM TARTRATE 167 163 32 23
DONEPEZIL HCL 161 152 33 29
ATENOLOL 157 145 34 15
SERTRALINE HCL 156 143 35 22
WARFARIN SODIUM 152 148 36 14
FLUTICASONE PROPIONATE 151 151 37 27
LOVASTATIN 147 147 38 37
LYRICA 141 134 39 111
SPIRIVA 139 136 40 44
LANTUS 130 129 41 57
QUETIAPINE FUMARATE 130 126 41 62
HYDROCODONE-ACETAMINOPHEN 122 104 S3 43 6
CLOPIDOGREL 120 120 44 43
MIRTAZAPINE 117 102 45 53
VESICARE 117 99 45 231
ZETIA 115 115 47 68
DETROL LA 112 112 48 263
ACTOS 108 92 49 117
MONTELUKAST SODIUM 106 106 50 144
GABAPENTIN 105 93 51 13
ENABLEX 101 89 52 316
CLONIDINE HCL 100 80 53 46
ADVAIR DISKUS 100 100 53 45
FAMOTIDINE 99 79 55 86
ROPINIROLE HCL 97 96 56 101
CYMBALTA 97 83 56 51
EXELON 97 97 56 187
AZITHROMYCIN 95 94 59 34
PLAVIX 95 95 59 66
PANTOPRAZOLE SODIUM 94 94 61 39
AVODART 92 85 62 173
FINASTERIDE 89 89 63 99
POTASSIUM CHLORIDE 88 68 64 20
FLUOCINONIDE 87 87 65 362
TRICOR 86 86 66 112
DILTIAZEM 24HR CD 84 84 67 96
GLIMEPIRIDE 83 83 68 32
TRIAMTERENE-HCTZ 82 82 69 61
BENICAR 81 81 70 217
VALSARTAN-HYDROCHLOROTHIAZIDE 80 76 71 321
TRILIPIX 80 67 71 198
ESCITALOPRAM OXALATE 78 69 73 76
DIGOXIN 78 78 73 85
HYDROCHLOROTHIAZIDE 73 73 75 9
CARBIDOPA-LEVODOPA 72 72 76 110
PATANOL 72 72 76 412
TOVIAZ 69 69 78 416
MICARDIS HCT 68 68 79 338
EXFORGE 65 65 80 229
CLOTRIMAZOLE-BETAMETHASONE 63 63 81 199
MICARDIS 61 61 82 298
ACTONEL 61 49 82 250
VOLTAREN 59 58 84 238
CIPROFLOXACIN HCL 58 56 85 65
TEKTURNA 58 58 85 373
ACTOPLUS MET 58 58 85 371
MECLIZINE HCL 57 57 88 124
SEROQUEL 54 47 89 130
GLIPIZIDE 52 44 90 47
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Oct. 7, 2013.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.